These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 16944706

  • 21. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R, Make B.
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [Abstract] [Full Text] [Related]

  • 22. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF, Hanania NA, Ciubotaru RL, Noe L, Pasta DJ, Schaefer K, Claus R, Andrews WT, Roach J.
    Clin Ther; 2008 Aug; 30 Spec No():989-1002. PubMed ID: 18640474
    [Abstract] [Full Text] [Related]

  • 23. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS.
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 27. Management of chronic obstructive pulmonary disease.
    Sutherland ER, Cherniack RM.
    N Engl J Med; 2004 Jun 24; 350(26):2689-97. PubMed ID: 15215485
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Kombipek in the therapy of patients with broncho-obstructive lung diseases].
    Chuchalin AG, Tsoĭ AN, Zaĭtseva TM, Titova EV, Medani SM, Smirnov MV, Kaziakhmedov EA.
    Ter Arkh; 1995 Jun 24; 67(6):26-9. PubMed ID: 7667774
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease].
    Xu YJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun 24; 26(3):319-22. PubMed ID: 15266839
    [Abstract] [Full Text] [Related]

  • 35. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD.
    Respirology; 2009 Mar 24; 14(2):260-3. PubMed ID: 19210659
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Theophylline in chronic obstructive pulmonary disease: new horizons.
    Barnes PJ.
    Proc Am Thorac Soc; 2005 Mar 24; 2(4):334-9; discussion 340-1. PubMed ID: 16267358
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.